Canada markets open in 3 hours 24 minutes

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.39+1.88 (+13.92%)
At close: 4:00PM EST

15.40 +0.01 (0.06%)
Pre-Market: 5:51AM EST

Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-03-31
Total Revenue
0
0
Operating Expenses
Research Development
64,157
47,927
Selling General and Administrative
35,526
18,151
Total Operating Expenses
99,683
66,078
Operating Income or Loss
-99,683
-66,078
Interest Expense
0
625
Total Other Income/Expenses Net
-479
412
Income Before Tax
-100,162
-66,291
Income Tax Expense
-338
97
Income from Continuing Operations
-99,824
-66,388
Net Income
-99,824
-66,388
Net Income available to common shareholders
-99,824
-66,388
Basic EPS
-
-1.54
Diluted EPS
-
-1.54
Basic Average Shares
-
43,199
Diluted Average Shares
-
43,199
EBITDA
-
-65,645